Mutation analysis of the tumor suppressor gene PPP2R1B in human cervical cancer

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 868-871

  Yeh, L S ^a   Hsieh, Y Y ^a,b   Chang, J G ^a   Chang, W W C ^a   Chang, C C ^a   Tsai, F J ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Cervical cancer; Loss of heterozygosity; PPP2R1B; Protein phosphatase 2A; Tumor suppressor gene

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; ISOENZYME; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN PPP2R1B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BETA CHAIN; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CODON; COMPARATIVE STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROTEIN PHOSPHATASE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 34447300471     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00880.x     Document Type: Article

References (26)

1. Baysal BE, Willett-Brozick JE, Taschner PE, Dauwerse JG, Devilee P, Devlin B. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. Eur J Hum Genet 2001 9: 121 9.
2. Pulido HA, Fakruddin MJ, Chatterjee A et al. Identification of a 6-cm minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 2000 60: 6677 82.
3. Baysal BE, Farr JE, Goss JR, Devlin B, Richard CW 3rd. Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23. Gene 1998 217: 107 16.
4. Takagi Y, Futamura M, Yamaguchi K, Aoki S, Takahashi T, Saji S. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. Gut 2000 47: 268 71.
5. Su TH, Chang JG, Perng LI et al. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol Oncol 2000 76: 193 9.
6. Chen YJ, Chen PH, Lee MD, Chang JG. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Int J Cancer 1997 72: 955 8.
7. Li L, Li X, Francke U, Cohen SN. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 1997 88: 143 54.
8. Allinen M, Peri L, Kujala S et al. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 2002 34: 384 9.
9. Takakura S, Kohno T, Manda R, Okamoto A, Tanaka T, Yokota J. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. Int J Oncol 2001 18: 817 24.
10. Salinas M, Lopez-Valdaliso R, Martin D, Alvarez A, Cuadrado A. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci 2000 15: 156 69.
11. Prinetti A, Bassi R, Riboni L, Tettamanti G. Involvement of a ceramide activated protein phosphatase in the differentiation of neuroblastoma Neuro2a cells. FEBS Lett 1997 414: 475 9.
12. Lee JY, Bielawska AE, Obeid LM. Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp Cell Res 2000 261: 303 11.
13. Lee TH, Solomon MJ, Mumby MC, Kirschner MW. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 1991 64: 415 23.
14. Li H, Zhao LL, Funder JW, Liu JP. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biolumin Chemilumin 1997 272: 16729 32.
15. Fujiki H, Suganuma M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 1993 61: 143 94.
16. Hemmer S, Wasenius VM, Haglund C et al. Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas. Cancer Genet Cytogenet 2002 134: 13 7.
17. Wang SS, Esplin ED, Li JL et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998 282: 284 7.
18. Calin GA, di Iasio MG, Caprini E et al. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000 19: 1191 5.
19. Wu R, Connolly DC, Ren X, Fearon ER, Cho KR. Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas. Neoplasia 1999 1: 311 4.
20. Gentile M, Ahnstrom M, Schon F, Wingren S. Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis. Oncogene 2001 20: 7753 60.
21. Wang SS, Virmani A, Gazdar AF, Minna JD, Evans GA. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer. Genes Chromosomes Cancer 1999 25: 154 9.
22. Ruteshouser EC, Ashworth LK, Huff V. Absence of PPP2R1A mutations in Wilms tumor. Oncogene 2001 20: 2050 4.
23. Zhu Y, Loukola A, Monni O et al. PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas. Leuk Lymphoma 2001 41: 177 83.
24. Campbell IG, Manolitsas T. Absence of PPP2R1B gene alterations in primary ovarian cancers. Oncogene 1999 18: 6367 9.
25. Tamaki M, Goi T, Hirono Y, Katayama K, Yamaguchi A. PPP2R1B gene alterations inhibit interaction of PP2A-A beta and PP2A-C proteins in colorectal cancers. Oncol Rep 2004 11: 655 9.
26. Zhang Z, Gerhard DS, Nguyen L et al. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. Genes Chromosomes Cancer 2005 43: 95 103.